Cases Rising 3% Annually as Experts Urge Screening
The American Cancer Society reports a 3% annual increase in prostate cancer diagnoses between 2014 and 2022, with a concerning rise in advanced-stage cases. Experts are urging men to prioritize early screening to improve survival rates and treatment outcomes.
Why it matters
Early detection is critical for managing prostate cancer, and the trend toward late-stage diagnosis highlights a significant public health challenge.
The ACS estimates that there will be 333,830 new cases of prostate cancer in 2026, with 36,320 deaths from the disease.
The ACS also reported in the Cancer Statistics 2026 report that cases of prostate cancer increased by 3% each year between 2014 and 2022. The steepest increase occurred in advanced-stage diagnoses.
Additionally, the ACS noted that the increase in diagnoses is largely due to more men being screened for the disease.
“We’re seeing two things happen at once: more men are being diagnosed with prostate cancer, and a growing share of those cases are happening at a more advanced stage,” William Dahut , MD, chief scientific officer at the ACS, said in a statement . “That tells us screening conversations are happening too late for too many men, particularly those at high risk for the disease.”
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in